Brain Protection Therapy in Acute Cerebral Infarction-Reference-Cited by-同舟云学术

Brain Protection Therapy in Acute Cerebral Infarction

Published:2012 Issue:2 Volume:79 Page:104-110
ISSN:1345-4676
Container-title:Journal of Nippon Medical School
language:en
Short-container-title:J Nippon Med Sch

Author:

Katsura Ken-ichiro¹,Suda Satoshi¹,Abe Arata¹,Kanamaru Takuya¹,Toda Yusuke¹,Katayama Yasuo¹

Affiliation:

1. Department of Neurological, Nephrological and Rheumatological Sciences, Graduate School of Medicine, Nippon Medical School

Publisher

Medical Association of Nippon Medical School

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jnms/79/2/79_104/_pdf

Reference21 articles.

1. 1. Warlow CP: Epidemiology of stroke. Lancet 1998; 352: 1-4.

2. 2. Health and Welfare Statistics Association of Japan. Annual Statistics Report of National Welfare Trends. Journal of Heath & Welfare Statistics, 2002.

3. 3. de Keyser J, Sulter G, Luiten PG: Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 1999; 22: 535-540.

4. 4. Kobayashi S: Stroke Data Bank 2009 (Kobayashi S, ed), 2009; Nakayama Shoten, Tokyo.

5. 5. Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke. Cochrane Syst Rev 2004 (2): CD000096.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long noncoding RNA KCNQ1OT1 aggravates cerebral infarction by regulating PTBT1/SIRT1 via miR-16-5p;Journal of Neuropathology & Experimental Neurology;2024-02-07

2. Long noncoding RNA CDKN2B‐AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription;The FASEB Journal;2019-03-14

3. Reflections on Neuroprotection Research and the Path Toward Clinical Success;Springer Series in Translational Stroke Research;2017

4. Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model;Oncotarget;2016-12-04

5. Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial;Clinical Drug Investigation;2016-06-10